Therapy News and Research

RSS

Study identifies ROS in the gaseous phase of cigarette smoke

A team of researchers led by A. K. Rajasekaran, PhD, Director of the Nemours Center for Childhood Cancer Research, has shown that a key protein involved in cell function and regulation is stopped by a substance present in cigarette smoke.

22 Mar 2012

Symposium to focus on oral health care workforce

On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Building the Oral Health Care Workforce: Multipronged Research on Dental Therapy" will take place to help attendees understand opportunities for effective utilization of new workforce models in nontraditional settings within the oral health care community.

22 Mar 2012

Alzheimer's may spread through connected neurons

Alzheimer's disease and other forms of dementia may spread within nerve networks in the brain by moving directly between connected neurons, instead of in other ways proposed by scientists, such as by propagating in all directions, according to researchers who report the finding in the March 22 edition of the journal Neuron.

22 Mar 2012

CBSM intervention can alter tumor-promoting processes in women with breast cancer

A team of researchers led by Michael H. Antoni, director of the Center for Psycho-Oncology Research at the University of Miami (UM) has shown that a stress management program tailored to women with breast cancer can alter tumor-promoting processes at the molecular level. The new study recently published in the journal Biological Psychiatry is one of the first to link psychological intervention with genetic expression in cancer patients.

22 Mar 2012

New method for in vivo study of unknown selenium metabolism

Spanish and Danish researchers have developed a method for the in vivo study of the unknown metabolism of selenium, an essential element for living beings. The technique can help clarify whether or not it possesses the anti-tumour properties that have been attributed to it and yet have not been verified through clinical trials.

22 Mar 2012

EMS responders can play a significant role in reducing MCTB time for STEMI patients

Health care practitioners have long understood the importance of "door to balloon" time for heart attack patients-the faster they can get the patient from the door of the hospital to a catheterization lab to open a clogged artery, the better the patient will do.

22 Mar 2012

Scientists reveal first-ever glimpse of complete kappa opioid receptor structure

At the molecular level, drugs like salvinorin A (the active ingredient of the hallucinogenic plant Salvia divinorum) work by activating specific proteins, known as receptors, in the brain and body.

22 Mar 2012

Peripheral nerve stimulation may help manage neuropathic pain in injured soldiers

An peripheral nerve stimulation technique may be a valuable new approach for relief of severe neuropathic (nerve-related) pain in injured soldiers, reports an article in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

22 Mar 2012

Patients with tinnitus may soon have a definitive therapy

Clinical trials of the new therapy, called Acoustic Coordinated Reset (ACR), have shown that it reduces the loudness and annoyance caused by tinnitus in seven out of 10 patients.

21 Mar 2012

CIBMTR report shows higher survival rate for patients treated at RPCI's BMT program

Outcomes for patients treated through the Blood and Marrow Transplant Program at Roswell Park Cancer Institute (RPCI) are among the highest in the nation. For the second consecutive year, a report compiled by the Center for International Blood and Marrow Transplant Research (CIBMTR) shows that the one-year survival rate for transplant patients treated at RPCI was significantly higher than expected, affirming RPCI's position among the elite of U.S. centers performing the procedure.

21 Mar 2012

Heart Failure Congress 2012 to take place from May 19-22

Four days of scientific sessions will be devoted to the latest advances and controversies in heart failure at this year's Heart Failure Congress 2012. The latest results from drugs and devices trials will be announced at the meeting.

21 Mar 2012

Fat-enclosed nanoparticles can directly irradiate brain tumor

For the past 40 years, radiation has been the most effective method for treating deadly brain tumors called glioblastomas. But, although the targeting technology has been refined, beams of radiation still must pass through healthy brain tissue to reach the tumor, and patients can only tolerate small amounts before developing serious side effects.

21 Mar 2012

Bone-marrow derived MSCs may reduce acute rejection rates in kidney recipients

Among patients with end-stage renal disease undergoing living-related kidney transplants, the use of bone-marrow derived mesenchymal (cells that can differentiate into a variety of cell types) stem cells instead of antibody induction therapy resulted in a lower incidence of acute rejection, decreased risk of opportunistic infection, and better estimated kidney function at 1 year, according to a study in the March 21 issue of JAMA.

21 Mar 2012

Two-year results from Boston Scientific's PROMUS Element trial to be presented at ACC 2012

Boston Scientific Corporation releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 24-27 in Chicago.

21 Mar 2012

MD Anderson, Transgenomic partner to evaluate use of ICE COLD-PCR

Transgenomic, Inc. today announced that it has begun a collaboration with The University of Texas MD Anderson Cancer Center to evaluate the use of the Company's very high sensitivity ICE COLD-PCR mutation detection technology in analysis of DNA isolated from circulating tumor cells (CTCs) in blood samples from patients with advanced cancer.

21 Mar 2012

TACT believes that Halo's HT-100 may effectively treat DMD

Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.

21 Mar 2012

Enrollment commences in Global Registry for Endovascular Aortic Treatment

W. L. Gore & Associates today reported the first Australian patients enrolled in the Global Registry for Endovascular Aortic Treatment.

21 Mar 2012

Factors that increase the possibility of having migraines

A migraine is the most common type of headache that propels patients to seek care from their doctors. Roughly 30 million Americans suffer from migraine headaches, with women affected almost three times more often than men, according to statistics from the National Headache Foundation in Chicago.

21 Mar 2012

OSU, NCKU sign MOU to improve clinical research on pancreatic cancer

National Cheng Kung University (NCKU) in Tainan, southern Taiwan, signed a memorandum of understanding (MOU) with the Ohio State University (OSU) College of Pharmacy on March 20 at the NCKU College of Medicine as part of its effort to enhance its international academic cooperation and most importantly to improve the clinical research on pancreatic cancer.

21 Mar 2012

IDSA releases new rhinosinusitis guidelines

The vast majority of sinus infections are caused by viruses and should not be treated with antibiotics, suggest new guidelines released by the Infectious Diseases Society of America.

21 Mar 2012